Author pages are created from data sourced from our academic publisher partnerships and public sources.
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.
- G. Barrière, P. Fici, G. Gallerani, F. Fabbri, W. Zoli, M. Rigaud
- Annals of translational medicine
- 30 October 2014
Until now detection and numeration of circulating tumor cells (CTCs) were essentially used as a prognostic factor in cancer progression. To extend the role of these kinds of analysis, it seems… Expand
Free DNA and Carcinoembryonic Antigen Serum Levels: An Important Combination for Diagnosis of Colorectal Cancer
Purpose: The identification of new molecular markers for the early detection of colorectal cancer has become an important objective. We compared the sensitivity and specificity of free circulating… Expand
Role of biological markers in the clinical outcome of colon cancer
We investigated a number of biological markers, evaluated under strict intralaboratory quality control conditions, in terms of their role in predicting clinical outcome of patients with colon cancer… Expand
Fecal multiple molecular tests to detect colorectal cancer in stool.
- D. Calistri, C. Rengucci, R. Bocchini, L. Saragoni, W. Zoli, D. Amadori
- Clinical gastroenterology and hepatology : the…
- 1 September 2003
BACKGROUND & AIMS Evaluation of molecular alterations in fecal DNA is a potential, noninvasive, alternative tool for the detection of colorectal cancer. We analyzed a large panel of molecular… Expand
In vitro preclinical models for a rational design of chemotherapy combinations in human tumors.
- W. Zoli, L. Ricotti, A. Tesei, F. Barzanti, D. Amadori
- Critical reviews in oncology/hematology
Today, drug combinations are frequently used in the treatment of cancer to increase therapeutic efficacy. Currently used clinical protocols for cancer combination therapies are mainly obtained… Expand
Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells
- F. Fabbri, D. Amadori, +8 authors R. Silvestrini
- Medicine, Biology
- Journal of cellular physiology
- 1 November 2008
Studies performed in different experimental and clinical settings have shown that Docetaxel (Doc) is effective in a wide range of tumors and that it exerts its activity through multiple mechanisms of… Expand
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach
- V. Casadio, C. Molinari, +8 authors W. Zoli
- Medicine, Biology
- Journal of experimental & clinical cancer…
- 19 November 2013
BackgroundAlthough non muscle invasive bladder cancer (NMIBC) generally has a good long-term prognosis, up to 80% of patients will nevertheless experience local recurrence after the primary tumor… Expand
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.
The characterization of circulating tumor cells (CTCs) could substantially improve the management of cancer patients. However, their study is still a matter of debate, often due to lymphocyte… Expand
c-kit and SCF Expression in Normal and Tumor Breast Tissue
- P. Ulivi, W. Zoli, +5 authors R. Silvestrini
- Biology, Medicine
- Breast Cancer Research and Treatment
Several studies have shown a role of the tyrosine kinase receptor, c-kit, and its ligand, SCF, during organogenesis, normal cell development and growth of some tumor histotypes. In breast cancer,… Expand
Multiple detection of genetic alterations in tumors and stool.
- C. Rengucci, P. Maiolo, L. Saragoni, W. Zoli, D. Amadori, D. Calistri
- Medicine, Biology
- Clinical cancer research : an official journal of…
- 1 March 2001
Detection of genetic alterations in exfoliated intestinal cells in stool could represent an alternative, noninvasive tool for the screening of colorectal tumors. To verify this, we analyzed p53 and… Expand